Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Louis V Kirchhoff, Keiko OtsufiledCriticalLouis V Kirchhoff
Priority to CR7891ApriorityCriticalpatent/CR7891A/en
Publication of CR7891ApublicationCriticalpatent/CR7891A/en
Medicines That Contain Protein Lipid Enzymes And Other Medicines
(AREA)
Abstract
Polipeptidos recombinantes se revelan que son utiles para diagnosticar la tripanosomiasis americana, o la enfermedad de Chagas, un padecimiento causado por el agente infeccioso Trypanosoma cruzi. Preferiblemente, las secuencias de ADN que codifican las proteinas recombinantes se insertan en plasmidos vehiculos para expresarse en un organismo.Recombinant polypeptides are revealed to be useful for diagnosing American trypanosomiasis, or Chagas disease, a condition caused by the infectious agent Trypanosoma cruzi. Preferably, the DNA sequences encoding recombinant proteins are inserted into vehicle plasmids to express themselves in an organism.
CR7891A2005-06-302005-06-30
RECOMBINANT POLYPEPTIDES TO DIAGNOSTICATE INFECTION WITH THE CRUZI TRYPANOSOMA
CR7891A
(en)
Substituted 2-amino-acetamide derived compounds; pharmaceutical composition; Useful in the treatment of lung diseases, rheumatic disease, autoimmune disease, among others.
Method for analyzing a human fluid sample by non-arterial and non-venous puncture or cellular sample, particularly a menstrual fluid sample, for the presence of at least one infectious disease.